These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38986818)

  • 1. Anti-CRMP2 antibody induces anxiety-like behavior and increases pyramidal neuron excitability in mice.
    Pan Y; Jiang Y; Wang D; Guo Z; He F; Chen Z; Dai C; Yuan Z; Chen R; Xu K; Hu Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167338. PubMed ID: 38986818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.
    Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T
    Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of CRMP2 is involved in proper bifurcation of the apical dendrite of hippocampal CA1 pyramidal neurons.
    Niisato E; Nagai J; Yamashita N; Nakamura F; Goshima Y; Ohshima T
    Dev Neurobiol; 2013 Feb; 73(2):142-51. PubMed ID: 22826151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
    Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
    Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K; Matsuura K; Nakamura-Hirota T; Takano M; Otani M; Matsuyama S
    J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CRMP2 by Cdk5 and GSK-3β participates in sevoflurane-induced dendritic development abnormalities and cognitive dysfunction in developing rats.
    Liao Z; Huang Z; Li J; Li H; Miao L; Liu Y; Zhang J; Xu Y; Li Y
    Toxicol Lett; 2021 May; 341():68-79. PubMed ID: 33548343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of CRMP2 by Cdk5 Regulates Dendritic Spine Development of Cortical Neuron in the Mouse Hippocampus.
    Jin X; Sasamoto K; Nagai J; Yamazaki Y; Saito K; Goshima Y; Inoue T; Ohshima T
    Neural Plast; 2016; 2016():6790743. PubMed ID: 26819770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal Endothelin-1 decreases excitability of pyramidal neurons and produces anxiolytic effects.
    Chen M; Shu S; Yan HH; Pei L; Wang ZF; Wan Q; Bi LL
    Neuropharmacology; 2017 May; 118():242-250. PubMed ID: 28302570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional protein kinase Cβ-mediated phosphorylation inhibits collapsin response-mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice.
    Yang X; Zhang X; Li Y; Han S; Howells DW; Li S; Li J
    J Neurochem; 2016 May; 137(3):446-59. PubMed ID: 26788931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization.
    Yamashita N; Ohshima T; Nakamura F; Kolattukudy P; Honnorat J; Mikoshiba K; Goshima Y
    J Neurosci; 2012 Jan; 32(4):1360-5. PubMed ID: 22279220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration.
    Varrin-Doyer M; Vincent P; Cavagna S; Auvergnon N; Noraz N; Rogemond V; Honnorat J; Moradi-Améli M; Giraudon P
    J Biol Chem; 2009 May; 284(19):13265-76. PubMed ID: 19276087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
    Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
    Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice.
    Nakamura H; Yamashita N; Kimura A; Kimura Y; Hirano H; Makihara H; Kawamoto Y; Jitsuki-Takahashi A; Yonezaki K; Takase K; Miyazaki T; Nakamura F; Tanaka F; Goshima Y
    Genes Cells; 2016 Oct; 21(10):1059-1079. PubMed ID: 27582038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine Regulates Phosphorylation of CRMP2 To Mediate Dendritic Spine Plasticity.
    Zhang Z; Zhang J; Li J; Zhang J; Chen L; Li Y; Guo G
    J Mol Neurosci; 2020 Mar; 70(3):353-364. PubMed ID: 31808033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice.
    Zhou H; Zhang R; Lu K; Yu W; Xie B; Cui D; Jiang L; Zhang Q; Xu S
    J Neurol Sci; 2016 Aug; 367():3-10. PubMed ID: 27423553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.